1 “... role in stage II disease is unclear. In treating 100 stage II patients with adjuvant chemotherapy...”

2 “... role in stage II disease is unclear. In treating 100 stage II patients with adjuvant chemotherapy...”

3 Subjects: “...Genes, erbB-2 / genetics...”

4 “... (pooled HR, 1.04; 95% CI, 0.99 to 1.10; I2 = 38%; 44 trials), but many trials did not include an overall...”

5 “... (pooled HR, 1.04; 95% CI, 0.99 to 1.10; I2 = 38%; 44 trials), but many trials did not include an overall...”

6

7

8 “... in the treatment of head and neck cancer including: conventional or two-dimensional (2DRT), three-dimensional...”

9 “... in the treatment of head and neck cancer including: conventional or two-dimensional (2DRT), three-dimensional...”

10 “...KQ2, which addressed the association between PFS and QOL, was designed to indirectly answer KQ1...”

11 “...KQ2, which addressed the association between PFS and QOL, was designed to indirectly answer KQ1...”

12 “... and healing. Recombinant DNA techniques have been used to produce BMP2 and BMP7 as alternatives to autograft...”

13 “... and healing. Recombinant DNA techniques have been used to produce BMP2 and BMP7 as alternatives to autograft...”

14 “...'s EPCs are prioritized, and (2) assess whether that process is found to be useful by decision makers...”

15 “...'s EPCs are prioritized, and (2) assess whether that process is found to be useful by decision makers...”

16 “... to xerostomia were improved in patients treated with IMRT compared with those who received either 3DCRT or 2DRT...”

17 “... to xerostomia were improved in patients treated with IMRT compared with those who received either 3DCRT or 2DRT...”

18 “... (PCR), intermediate turnaround time (results available next day to 2 days after testing performed...”

19 “... (PCR), intermediate turnaround time (results available next day to 2 days after testing performed...”

20